Changeflow GovPing Pharma & Drug Safety Two-phase system patent - PM-International AG
Routine Notice Added Final

Two-phase system patent - PM-International AG

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Pharma (A61K)
Published March 25th, 2026
Detected April 2nd, 2026
Email

Summary

The European Patent Office published patent application EP3908127A1 for PM-International AG, covering a two-phase system composition. The invention relates to cosmetic preparations (A61K 8/92) with anti-wrinkle properties (A61Q 7/00) and includes oil-based formulations (A23L 33/115) and plant extracts (A23L 33/105). Designated states include all EU member states plus Switzerland, Norway, and other EP contracting states.

What changed

The EPO published patent application EP3908127A1 for a two-phase system invented by Rolf Sorg and colleagues. The application covers cosmetic compositions using oil-based carriers (A61K 8/92), plant-derived active ingredients (A61K 8/9767, A61K 8/9794), and food-grade components (A23L classifications). The designated states extend protection across 34 European jurisdictions including all EU member states.

Patent publications are informational notices confirming the filing and making the application publicly available. PM-International AG should monitor the patent prosecution timeline, including the 31-month deadline to validate in designated states and respond to any EPO examination reports. Competitors developing similar two-phase cosmetic or nutritional formulations should review the claims upon grant to assess freedom-to-operate implications.

Source document (simplified)

← EPO Patent Bulletin

TWO-PHASE SYSTEM

Publication EP3908127A1 Kind: A1 Mar 25, 2026

Applicants

PM-International AG

Inventors

SORG, Rolf, MESSER, Wilhelm, LAUINGER, Christian, MEINHARDT, Horst, HERZ, Karina

IPC Classifications

A23L 33/15 20160101AFI20260217BHEP A23L 35/00 20160101ALI20260217BHEP A61K 8/92 20060101ALI20260217BHEP A61K 8/9767 20170101ALI20260217BHEP A61K 8/9794 20170101ALI20260217BHEP A23L 29/10 20160101ALI20260217BHEP A23L 33/115 20160101ALI20260217BHEP A61Q 7/00 20060101ALI20260217BHEP A23L 33/105 20160101ALI20260217BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

Two-phase system IPC Classifications A61K 8/92 IPC Classifications A61Q 7/00 Designated States

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 25th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP3908127A1

Who this affects

Applies to
Drug manufacturers Consumers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent Filing Cosmetic Formulations Nutritional Compositions
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Intellectual Property Consumer Protection

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.